Global Patient Derived Xenograft & PDX Models Supply, Demand and Key Producers, 2023-2029

Page: 109

Published Date: 03 Mar 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Patient derived xenografts (PDX) are models of cancer where the tissue or cells from a patient's tumor are implanted into an immunodeficient or humanized mouse. PDX models are used to create an environment that allows for the natural growth of cancer, its monitoring, and corresponding treatment evaluations for the original patient.

This report studies the global Patient Derived Xenograft & PDX Models demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Patient Derived Xenograft & PDX Models, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Patient Derived Xenograft & PDX Models that contribute to its increasing demand across many markets.

The global Patient Derived Xenograft & PDX Models market size is expected to reach $ 589.9 million by 2029, rising at a market growth of 8.1% CAGR during the forecast period (2023-2029).

Global top 5 manufacturers of patient-derived xenograft (PDX) models occupied for a share nearly 45 percent, key players are Crown Bioscience, Champions Oncology, Wuxi Apptec, EPO Berlin-Buch, and Oncodesign, etc. Geographically speaking, Asia Pacific holds the most of global market share, about 35%. North America holds about 30% of share, while Europe followed by nearly 20%. In terms of type, mouse model accounted for nearly 75%, and rat model accounted for a share of 25%,The application of patient-derived xenograft (PDX) models includes preclinical drug development and biomarker analysis. Preclinical drug development shares over 75%, while biomarker analysis shares about 20%.

Highlights and key features of the study
Global Patient Derived Xenograft & PDX Models total market, 2018-2029, (USD Million)
Global Patient Derived Xenograft & PDX Models total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Patient Derived Xenograft & PDX Models total market, key domestic companies and share, (USD Million)
Global Patient Derived Xenograft & PDX Models revenue by player and market share 2018-2023, (USD Million)
Global Patient Derived Xenograft & PDX Models total market by Type, CAGR, 2018-2029, (USD Million)
Global Patient Derived Xenograft & PDX Models total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Patient Derived Xenograft & PDX Models market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Crown Bioscience, The Jackson Laboratory, Champions Oncology, Charles River Laboratories, WuXi Apptec, Oncodesign, Horizon Discovery, Pharmatest Services and Hera Biolabs, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Patient Derived Xenograft & PDX Models market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Patient Derived Xenograft & PDX Models Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Patient Derived Xenograft & PDX Models Market, Segmentation by Type
    Mice Models
    Rat Models

Global Patient Derived Xenograft & PDX Models Market, Segmentation by Application
    Pre-clinical Drug Development and Basic Cancer Research
    Biomarker Analysis

Companies Profiled:
    Crown Bioscience
    The Jackson Laboratory
    Champions Oncology
    Charles River Laboratories
    WuXi Apptec
    Oncodesign
    Horizon Discovery
    Pharmatest Services
    Hera Biolabs
    EPO Berlin-Buch
    Xentech
    Urolead

Key Questions Answered
1. How big is the global Patient Derived Xenograft & PDX Models market?
2. What is the demand of the global Patient Derived Xenograft & PDX Models market?
3. What is the year over year growth of the global Patient Derived Xenograft & PDX Models market?
4. What is the total value of the global Patient Derived Xenograft & PDX Models market?
5. Who are the major players in the global Patient Derived Xenograft & PDX Models market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Patient Derived Xenograft & PDX Models Introduction
    1.2 World Patient Derived Xenograft & PDX Models Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Patient Derived Xenograft & PDX Models Total Market by Region (by Headquarter Location)
        1.3.1 World Patient Derived Xenograft & PDX Models Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Patient Derived Xenograft & PDX Models Market Size (2018-2029)
        1.3.3 China Patient Derived Xenograft & PDX Models Market Size (2018-2029)
        1.3.4 Europe Patient Derived Xenograft & PDX Models Market Size (2018-2029)
        1.3.5 Japan Patient Derived Xenograft & PDX Models Market Size (2018-2029)
        1.3.6 South Korea Patient Derived Xenograft & PDX Models Market Size (2018-2029)
        1.3.7 ASEAN Patient Derived Xenograft & PDX Models Market Size (2018-2029)
        1.3.8 India Patient Derived Xenograft & PDX Models Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Patient Derived Xenograft & PDX Models Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Patient Derived Xenograft & PDX Models Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Patient Derived Xenograft & PDX Models Consumption Value (2018-2029)
    2.2 World Patient Derived Xenograft & PDX Models Consumption Value by Region
        2.2.1 World Patient Derived Xenograft & PDX Models Consumption Value by Region (2018-2023)
        2.2.2 World Patient Derived Xenograft & PDX Models Consumption Value Forecast by Region (2024-2029)
    2.3 United States Patient Derived Xenograft & PDX Models Consumption Value (2018-2029)
    2.4 China Patient Derived Xenograft & PDX Models Consumption Value (2018-2029)
    2.5 Europe Patient Derived Xenograft & PDX Models Consumption Value (2018-2029)
    2.6 Japan Patient Derived Xenograft & PDX Models Consumption Value (2018-2029)
    2.7 South Korea Patient Derived Xenograft & PDX Models Consumption Value (2018-2029)
    2.8 ASEAN Patient Derived Xenograft & PDX Models Consumption Value (2018-2029)
    2.9 India Patient Derived Xenograft & PDX Models Consumption Value (2018-2029)

3 World Patient Derived Xenograft & PDX Models Companies Competitive Analysis
    3.1 World Patient Derived Xenograft & PDX Models Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Patient Derived Xenograft & PDX Models Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Patient Derived Xenograft & PDX Models in 2022
        3.2.3 Global Concentration Ratios (CR8) for Patient Derived Xenograft & PDX Models in 2022
    3.3 Patient Derived Xenograft & PDX Models Company Evaluation Quadrant
    3.4 Patient Derived Xenograft & PDX Models Market: Overall Company Footprint Analysis
        3.4.1 Patient Derived Xenograft & PDX Models Market: Region Footprint
        3.4.2 Patient Derived Xenograft & PDX Models Market: Company Product Type Footprint
        3.4.3 Patient Derived Xenograft & PDX Models Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Patient Derived Xenograft & PDX Models Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Patient Derived Xenograft & PDX Models Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Patient Derived Xenograft & PDX Models Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Patient Derived Xenograft & PDX Models Consumption Value Comparison
        4.2.1 United States VS China: Patient Derived Xenograft & PDX Models Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Patient Derived Xenograft & PDX Models Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Patient Derived Xenograft & PDX Models Companies and Market Share, 2018-2023
        4.3.1 United States Based Patient Derived Xenograft & PDX Models Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Patient Derived Xenograft & PDX Models Revenue, (2018-2023)
    4.4 China Based Companies Patient Derived Xenograft & PDX Models Revenue and Market Share, 2018-2023
        4.4.1 China Based Patient Derived Xenograft & PDX Models Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Patient Derived Xenograft & PDX Models Revenue, (2018-2023)
    4.5 Rest of World Based Patient Derived Xenograft & PDX Models Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Patient Derived Xenograft & PDX Models Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Patient Derived Xenograft & PDX Models Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Patient Derived Xenograft & PDX Models Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Mice Models
        5.2.2 Rat Models
    5.3 Market Segment by Type
        5.3.1 World Patient Derived Xenograft & PDX Models Market Size by Type (2018-2023)
        5.3.2 World Patient Derived Xenograft & PDX Models Market Size by Type (2024-2029)
        5.3.3 World Patient Derived Xenograft & PDX Models Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Patient Derived Xenograft & PDX Models Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Pre-clinical Drug Development and Basic Cancer Research
        6.2.2 Biomarker Analysis
    6.3 Market Segment by Application
        6.3.1 World Patient Derived Xenograft & PDX Models Market Size by Application (2018-2023)
        6.3.2 World Patient Derived Xenograft & PDX Models Market Size by Application (2024-2029)
        6.3.3 World Patient Derived Xenograft & PDX Models Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Crown Bioscience
        7.1.1 Crown Bioscience Details
        7.1.2 Crown Bioscience Major Business
        7.1.3 Crown Bioscience Patient Derived Xenograft & PDX Models Product and Services
        7.1.4 Crown Bioscience Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Crown Bioscience Recent Developments/Updates
        7.1.6 Crown Bioscience Competitive Strengths & Weaknesses
    7.2 The Jackson Laboratory
        7.2.1 The Jackson Laboratory Details
        7.2.2 The Jackson Laboratory Major Business
        7.2.3 The Jackson Laboratory Patient Derived Xenograft & PDX Models Product and Services
        7.2.4 The Jackson Laboratory Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 The Jackson Laboratory Recent Developments/Updates
        7.2.6 The Jackson Laboratory Competitive Strengths & Weaknesses
    7.3 Champions Oncology
        7.3.1 Champions Oncology Details
        7.3.2 Champions Oncology Major Business
        7.3.3 Champions Oncology Patient Derived Xenograft & PDX Models Product and Services
        7.3.4 Champions Oncology Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Champions Oncology Recent Developments/Updates
        7.3.6 Champions Oncology Competitive Strengths & Weaknesses
    7.4 Charles River Laboratories
        7.4.1 Charles River Laboratories Details
        7.4.2 Charles River Laboratories Major Business
        7.4.3 Charles River Laboratories Patient Derived Xenograft & PDX Models Product and Services
        7.4.4 Charles River Laboratories Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Charles River Laboratories Recent Developments/Updates
        7.4.6 Charles River Laboratories Competitive Strengths & Weaknesses
    7.5 WuXi Apptec
        7.5.1 WuXi Apptec Details
        7.5.2 WuXi Apptec Major Business
        7.5.3 WuXi Apptec Patient Derived Xenograft & PDX Models Product and Services
        7.5.4 WuXi Apptec Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 WuXi Apptec Recent Developments/Updates
        7.5.6 WuXi Apptec Competitive Strengths & Weaknesses
    7.6 Oncodesign
        7.6.1 Oncodesign Details
        7.6.2 Oncodesign Major Business
        7.6.3 Oncodesign Patient Derived Xenograft & PDX Models Product and Services
        7.6.4 Oncodesign Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Oncodesign Recent Developments/Updates
        7.6.6 Oncodesign Competitive Strengths & Weaknesses
    7.7 Horizon Discovery
        7.7.1 Horizon Discovery Details
        7.7.2 Horizon Discovery Major Business
        7.7.3 Horizon Discovery Patient Derived Xenograft & PDX Models Product and Services
        7.7.4 Horizon Discovery Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Horizon Discovery Recent Developments/Updates
        7.7.6 Horizon Discovery Competitive Strengths & Weaknesses
    7.8 Pharmatest Services
        7.8.1 Pharmatest Services Details
        7.8.2 Pharmatest Services Major Business
        7.8.3 Pharmatest Services Patient Derived Xenograft & PDX Models Product and Services
        7.8.4 Pharmatest Services Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Pharmatest Services Recent Developments/Updates
        7.8.6 Pharmatest Services Competitive Strengths & Weaknesses
    7.9 Hera Biolabs
        7.9.1 Hera Biolabs Details
        7.9.2 Hera Biolabs Major Business
        7.9.3 Hera Biolabs Patient Derived Xenograft & PDX Models Product and Services
        7.9.4 Hera Biolabs Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Hera Biolabs Recent Developments/Updates
        7.9.6 Hera Biolabs Competitive Strengths & Weaknesses
    7.10 EPO Berlin-Buch
        7.10.1 EPO Berlin-Buch Details
        7.10.2 EPO Berlin-Buch Major Business
        7.10.3 EPO Berlin-Buch Patient Derived Xenograft & PDX Models Product and Services
        7.10.4 EPO Berlin-Buch Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 EPO Berlin-Buch Recent Developments/Updates
        7.10.6 EPO Berlin-Buch Competitive Strengths & Weaknesses
    7.11 Xentech
        7.11.1 Xentech Details
        7.11.2 Xentech Major Business
        7.11.3 Xentech Patient Derived Xenograft & PDX Models Product and Services
        7.11.4 Xentech Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Xentech Recent Developments/Updates
        7.11.6 Xentech Competitive Strengths & Weaknesses
    7.12 Urolead
        7.12.1 Urolead Details
        7.12.2 Urolead Major Business
        7.12.3 Urolead Patient Derived Xenograft & PDX Models Product and Services
        7.12.4 Urolead Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Urolead Recent Developments/Updates
        7.12.6 Urolead Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Patient Derived Xenograft & PDX Models Industry Chain
    8.2 Patient Derived Xenograft & PDX Models Upstream Analysis
    8.3 Patient Derived Xenograft & PDX Models Midstream Analysis
    8.4 Patient Derived Xenograft & PDX Models Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Patient Derived Xenograft & PDX Models Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Patient Derived Xenograft & PDX Models Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Patient Derived Xenograft & PDX Models Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Patient Derived Xenograft & PDX Models Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Patient Derived Xenograft & PDX Models Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Patient Derived Xenograft & PDX Models Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Patient Derived Xenograft & PDX Models Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Patient Derived Xenograft & PDX Models Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Patient Derived Xenograft & PDX Models Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Patient Derived Xenograft & PDX Models Players in 2022
    Table 12. World Patient Derived Xenograft & PDX Models Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Patient Derived Xenograft & PDX Models Company Evaluation Quadrant
    Table 14. Head Office of Key Patient Derived Xenograft & PDX Models Player
    Table 15. Patient Derived Xenograft & PDX Models Market: Company Product Type Footprint
    Table 16. Patient Derived Xenograft & PDX Models Market: Company Product Application Footprint
    Table 17. Patient Derived Xenograft & PDX Models Mergers & Acquisitions Activity
    Table 18. United States VS China Patient Derived Xenograft & PDX Models Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Patient Derived Xenograft & PDX Models Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Patient Derived Xenograft & PDX Models Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Patient Derived Xenograft & PDX Models Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Patient Derived Xenograft & PDX Models Revenue Market Share (2018-2023)
    Table 23. China Based Patient Derived Xenograft & PDX Models Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Patient Derived Xenograft & PDX Models Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Patient Derived Xenograft & PDX Models Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Patient Derived Xenograft & PDX Models Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Patient Derived Xenograft & PDX Models Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Patient Derived Xenograft & PDX Models Revenue Market Share (2018-2023)
    Table 29. World Patient Derived Xenograft & PDX Models Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Patient Derived Xenograft & PDX Models Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Patient Derived Xenograft & PDX Models Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Patient Derived Xenograft & PDX Models Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Patient Derived Xenograft & PDX Models Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Patient Derived Xenograft & PDX Models Market Size by Application (2024-2029) & (USD Million)
    Table 35. Crown Bioscience Basic Information, Area Served and Competitors
    Table 36. Crown Bioscience Major Business
    Table 37. Crown Bioscience Patient Derived Xenograft & PDX Models Product and Services
    Table 38. Crown Bioscience Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Crown Bioscience Recent Developments/Updates
    Table 40. Crown Bioscience Competitive Strengths & Weaknesses
    Table 41. The Jackson Laboratory Basic Information, Area Served and Competitors
    Table 42. The Jackson Laboratory Major Business
    Table 43. The Jackson Laboratory Patient Derived Xenograft & PDX Models Product and Services
    Table 44. The Jackson Laboratory Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. The Jackson Laboratory Recent Developments/Updates
    Table 46. The Jackson Laboratory Competitive Strengths & Weaknesses
    Table 47. Champions Oncology Basic Information, Area Served and Competitors
    Table 48. Champions Oncology Major Business
    Table 49. Champions Oncology Patient Derived Xenograft & PDX Models Product and Services
    Table 50. Champions Oncology Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Champions Oncology Recent Developments/Updates
    Table 52. Champions Oncology Competitive Strengths & Weaknesses
    Table 53. Charles River Laboratories Basic Information, Area Served and Competitors
    Table 54. Charles River Laboratories Major Business
    Table 55. Charles River Laboratories Patient Derived Xenograft & PDX Models Product and Services
    Table 56. Charles River Laboratories Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Charles River Laboratories Recent Developments/Updates
    Table 58. Charles River Laboratories Competitive Strengths & Weaknesses
    Table 59. WuXi Apptec Basic Information, Area Served and Competitors
    Table 60. WuXi Apptec Major Business
    Table 61. WuXi Apptec Patient Derived Xenograft & PDX Models Product and Services
    Table 62. WuXi Apptec Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. WuXi Apptec Recent Developments/Updates
    Table 64. WuXi Apptec Competitive Strengths & Weaknesses
    Table 65. Oncodesign Basic Information, Area Served and Competitors
    Table 66. Oncodesign Major Business
    Table 67. Oncodesign Patient Derived Xenograft & PDX Models Product and Services
    Table 68. Oncodesign Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Oncodesign Recent Developments/Updates
    Table 70. Oncodesign Competitive Strengths & Weaknesses
    Table 71. Horizon Discovery Basic Information, Area Served and Competitors
    Table 72. Horizon Discovery Major Business
    Table 73. Horizon Discovery Patient Derived Xenograft & PDX Models Product and Services
    Table 74. Horizon Discovery Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Horizon Discovery Recent Developments/Updates
    Table 76. Horizon Discovery Competitive Strengths & Weaknesses
    Table 77. Pharmatest Services Basic Information, Area Served and Competitors
    Table 78. Pharmatest Services Major Business
    Table 79. Pharmatest Services Patient Derived Xenograft & PDX Models Product and Services
    Table 80. Pharmatest Services Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Pharmatest Services Recent Developments/Updates
    Table 82. Pharmatest Services Competitive Strengths & Weaknesses
    Table 83. Hera Biolabs Basic Information, Area Served and Competitors
    Table 84. Hera Biolabs Major Business
    Table 85. Hera Biolabs Patient Derived Xenograft & PDX Models Product and Services
    Table 86. Hera Biolabs Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Hera Biolabs Recent Developments/Updates
    Table 88. Hera Biolabs Competitive Strengths & Weaknesses
    Table 89. EPO Berlin-Buch Basic Information, Area Served and Competitors
    Table 90. EPO Berlin-Buch Major Business
    Table 91. EPO Berlin-Buch Patient Derived Xenograft & PDX Models Product and Services
    Table 92. EPO Berlin-Buch Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. EPO Berlin-Buch Recent Developments/Updates
    Table 94. EPO Berlin-Buch Competitive Strengths & Weaknesses
    Table 95. Xentech Basic Information, Area Served and Competitors
    Table 96. Xentech Major Business
    Table 97. Xentech Patient Derived Xenograft & PDX Models Product and Services
    Table 98. Xentech Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Xentech Recent Developments/Updates
    Table 100. Urolead Basic Information, Area Served and Competitors
    Table 101. Urolead Major Business
    Table 102. Urolead Patient Derived Xenograft & PDX Models Product and Services
    Table 103. Urolead Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 104. Global Key Players of Patient Derived Xenograft & PDX Models Upstream (Raw Materials)
    Table 105. Patient Derived Xenograft & PDX Models Typical Customers
List of Figure
    Figure 1. Patient Derived Xenograft & PDX Models Picture
    Figure 2. World Patient Derived Xenograft & PDX Models Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Patient Derived Xenograft & PDX Models Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Patient Derived Xenograft & PDX Models Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Patient Derived Xenograft & PDX Models Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Patient Derived Xenograft & PDX Models Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Patient Derived Xenograft & PDX Models Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Patient Derived Xenograft & PDX Models Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Patient Derived Xenograft & PDX Models Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Patient Derived Xenograft & PDX Models Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Patient Derived Xenograft & PDX Models Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Patient Derived Xenograft & PDX Models Revenue (2018-2029) & (USD Million)
    Figure 13. Patient Derived Xenograft & PDX Models Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Patient Derived Xenograft & PDX Models Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Patient Derived Xenograft & PDX Models Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Patient Derived Xenograft & PDX Models Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Patient Derived Xenograft & PDX Models Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Patient Derived Xenograft & PDX Models Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Patient Derived Xenograft & PDX Models Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Patient Derived Xenograft & PDX Models Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Patient Derived Xenograft & PDX Models Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Patient Derived Xenograft & PDX Models Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Patient Derived Xenograft & PDX Models by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Patient Derived Xenograft & PDX Models Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Patient Derived Xenograft & PDX Models Markets in 2022
    Figure 27. United States VS China: Patient Derived Xenograft & PDX Models Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Patient Derived Xenograft & PDX Models Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Patient Derived Xenograft & PDX Models Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Patient Derived Xenograft & PDX Models Market Size Market Share by Type in 2022
    Figure 31. Mice Models
    Figure 32. Rat Models
    Figure 33. World Patient Derived Xenograft & PDX Models Market Size Market Share by Type (2018-2029)
    Figure 34. World Patient Derived Xenograft & PDX Models Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Patient Derived Xenograft & PDX Models Market Size Market Share by Application in 2022
    Figure 36. Pre-clinical Drug Development and Basic Cancer Research
    Figure 37. Biomarker Analysis
    Figure 38. Patient Derived Xenograft & PDX Models Industrial Chain
    Figure 39. Methodology
    Figure 40. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Patient Derived Xenograft & PDX Models Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Patient Derived Xenograft & PDX Models Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 02 Jan 2023

date Medical Care

Patient derived xenografts (PDX) are models of cancer where the tissue or cells from a patient's tumor are implanted into an immunodeficient or humanized mouse. PDX models are used to create an environment that allows for the natural growth of cancer, its monitoring, and corresponding treatment evaluations for the original patient.

Global Patient Derived Xenograft & PDX Models Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Patient Derived Xenograft & PDX Models Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 25 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Patient Derived Xenograft & PDX Models market size was valued at USD 341.2 million in 2023 and is forecast to a readjusted size of USD 589.9 million by 2030 with a CAGR of 8.1% during review period.

Product Tags

Patient-derived Xenograft (PDX) Models

Patient Derived Xenograft & PDX Models

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>